<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Azathioprine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00993</strong>&#160; (APRD00811)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>An immunosuppressive antimetabolite pro-drug. It is an imidazolyl derivative of 6-mercaptopurine and many of its biological effects are similar to those of the parent compound. Azathioprine is converted into 6-mercaptopurine in the body where it blocks purine metabolism and <span class="caps">DNA</span> synthesis.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00993/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00993/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00993.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00993.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00993.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00993.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00993.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00993">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Azathioprine Sodium</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000012/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000012/thumb.png"></a></td>
        <td>
            <ul>
              <li>InChI Key: WISNYKIQFMKSDQ-UHFFFAOYSA-N</li>
              <li>Monoisotopic Mass: 299.020137836</li>
              <li>Average Mass: 299.244</li>
            </ul>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000012">DBSALT000012</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Azamun</td><td>Ascent</td></tr><tr><td>Azanin</td><td>Tanabe Mitsubishi Pharma</td></tr><tr><td>Azasan</td><td>AAIPharma</td></tr><tr><td>Imuran</td><td>GlaxoSmithKline</td></tr><tr><td>Imurek</td><td>Aspen</td></tr><tr><td>Imurel</td><td>GlaxoSmithKline</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/antirheumatic-agents">Antirheumatic Agents</a></li>
<li><a href="/mesh/immunosuppressive-agents">Immunosuppressive Agents</a></li>
<li><a href="/mesh/antimetabolites">Antimetabolites</a></li>
<li><a href="/mesh/antimetabolites-antineoplastic">Antimetabolites, Antineoplastic</a></li></ul></td></tr><tr><th>CAS number</th><td>446-86-6</td></tr><tr><th>Weight</th><td>Average: 277.263<br>Monoisotopic: 277.038193193</td></tr><tr><th>Chemical Formula</th><td>C<sub>9</sub>H<sub>7</sub>N<sub>7</sub>O<sub>2</sub>S</td></tr><tr><th>InChI Key</th><td>LMEKQMALGUDUQG-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Heterocyclic Compounds</td></tr><tr><th>Class</th><td>Imidazopyrimidines</td></tr><tr><th>Subclass</th><td>Purines and Purine Derivatives</td></tr><tr><th>Direct parent</th><td>Purines and Purine Derivatives</td></tr><tr><th>Alternative parents</th><td>Nitroimidazoles; Pyrimidines and Pyrimidine Derivatives; N-substituted Imidazoles; Nitro Compounds; Nitronic Acids; Organic Oxoazanium Compounds; Polyamines; Thioethers</td></tr><tr><th>Substituents</th><td>nitroimidazole; n-substituted imidazole; pyrimidine; imidazole; azole; nitro compound; nitronic acid; polyamine; thioether; organic oxoazanium; organonitrogen compound; amine</td></tr><tr><th>Classification description</th><td>This compound belongs to the purines and purine derivatives. These are aromatic heterocyclic compounds containing a purine moiety, which is formed a pyrimidine-ring ring fused to an imidazole ring.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For use in rheumatoid arthritis, preventing renal transplant rejection, Crohn's disease, and colitis.</td></tr><tr><th>Pharmacodynamics</th><td>Azathioprine is a chemotherapy drug, now rarely used for chemotherapy but more for immunosuppression in organ transplantation and autoimmune disease such as rheumatoid arthritis or inflammatory bowel disease or Crohn's disease. It is a pro-drug, converted in the body to the active metabolite 6-mercaptopurine. Azathioprine acts to inhibit purine synthesis necessary for the proliferation of cells, especially leukocytes and lymphocytes. It is a safe and effective drug used alone in certain autoimmune diseases, or in combination with other immunosuppressants in organ transplantation. Its most severe side effect is bone marrow suppression, and it should not be given in conjunction with purine analogues such as allopurinol. The enzyme thiopurine S-methyltransferase (TPMT) deactivates 6-mercaptopurine. Genetic polymorphisms of TPMT can lead to excessive drug toxicity, thus assay of serum TPMT may be useful to prevent this complication.</td></tr><tr><th>Mechanism of action</th><td>Azathioprine antagonizes purine metabolism and may inhibit synthesis of DNA, RNA, and proteins. It may also interfere with cellular metabolism and inhibit mitosis. Its mechanism of action is likely due to incorporation of thiopurine analogues into the DNA structure, causing chain termination and cytotoxicity.</td></tr><tr><th>Absorption</th><td>Well absorbed following oral administration.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>Azathioprine and the metabolite mercaptopurine are moderately bound to serum proteins (30%).</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Primarily converted to the active metabolites 6-mercaptopurine and 6-thioinosinic acid via a non-enzymatica process and glutathione transferases. Activation of 6-mercaptopurine occurs via hypoxanthine-guanine phosphoribosyltransferase (HGPRT) and a series of multi-enzymatic processes involving kinases to form 6-thioguanine nucleotides (6-TGNs) as major metabolites</p><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0000987" target="_blank">Thiopurine S-methyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET00416">S-methylazathioprine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/419">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00623">6-Thioguanine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/642">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0000807" target="_blank">Glutathione S-transferase Mu 1</a></li>
<li><a href="/biodb/bio_entities/BE0002281" target="_blank">Glutathione S-transferase A1</a></li>
<li><a href="/biodb/bio_entities/BE0002189" target="_blank">Glutathione S-transferase A2</a></li></ul></td><td><a href="/metabolites/DBMET00630">6-Mercaptopurine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/650">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00768">6-thioguanylic acid</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/789">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00769">6-thioinosine triphosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/790">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00770">6-thioinosinic acid</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/791">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00771">6-thioxanthylic acid</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/792">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00780">8-hydroxythioguanine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/801">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01006">Thio-deoxyguanosine triphosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1029">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01007">Thioguanine diphosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1030">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01008">Thioguanine triphosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1031">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01009">6-thiouric acid</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1032">Details</a></td></tr><tr><td>Azathioprine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01010">6-Thioxanthine 5'-monophosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1033">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td>Both compounds are rapidly eliminated from blood and are oxidized or methylated in erythrocytes and liver; no azathioprine or mercaptopurine is detectable in urine after 8 hours. </td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>The oral LD<sub>50</sub> for single doses of azathioprine in mice and rats are 2500 mg/kg and 400 mg/kg, respectively. Very large doses of this antimetabolite may lead to marrow hypoplasia, bleeding, infection, and death.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th></tr></thead><tbody><tr><td>Azathioprine Action Pathway</td><td>Drug action</td></tr><tr><td>Azathioprine Metabolism Pathway</td><td>Drug metabolism</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00645?highlight%5Bcompounds%5D%5B%5D=DB00993&amp;highlight%5Bproteins%5D%5B%5D=DB00993">SMP00645</a></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="snp-fx"><thead><tr><th>Interacting Gene/Enzyme</th><th>SNP RS ID</th><th>Allele name</th><th>Defining change</th><th>Adverse Reaction</th><th>Reference(s)</th></tr></thead><tbody><tr><td>Thiopurine S-methyltransferase<br>Gene symbol: TPMT<br>UniProt: <a class="wishart-link-out" href="http://www.uniprot.org/uniprot/P51580" target="_blank">P51580 <span class="glyphicon glyphicon-new-window"> </span></a></td><td><a class="wishart-link-out" href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs1800462" target="_blank">rs1800462 <span class="glyphicon glyphicon-new-window"> </span></a></td><td>TMPT*2</td><td>G Allele</td><td>Hepatotoxicity</td><td><span class="citation"><a class="pubmed-link wishart-link-out" data-toggle="tooltip" href="http://www.ncbi.nlm.nih.gov/pubmed/16509759" target="_blank" title="Bosch TM, Meijerman I, Beijnen JH, Schellens JH: Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet. 2006;45(3):253-85.">16509759 <span class="glyphicon glyphicon-new-window"> </span></a></span></td></tr><tr><td>Thiopurine S-methyltransferase<br>Gene symbol: TPMT<br>UniProt: <a class="wishart-link-out" href="http://www.uniprot.org/uniprot/P51580" target="_blank">P51580 <span class="glyphicon glyphicon-new-window"> </span></a></td><td><a class="wishart-link-out" href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs1800460" target="_blank">rs1800460 <span class="glyphicon glyphicon-new-window"> </span></a></td><td>TMPT*3A</td><td>A Allele</td><td>Hepatotoxicity</td><td><span class="citation"><a class="pubmed-link wishart-link-out" data-toggle="tooltip" href="http://www.ncbi.nlm.nih.gov/pubmed/16509759" target="_blank" title="Bosch TM, Meijerman I, Beijnen JH, Schellens JH: Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet. 2006;45(3):253-85.">16509759 <span class="glyphicon glyphicon-new-window"> </span></a></span></td></tr><tr><td>Thiopurine S-methyltransferase<br>Gene symbol: TPMT<br>UniProt: <a class="wishart-link-out" href="http://www.uniprot.org/uniprot/P51580" target="_blank">P51580 <span class="glyphicon glyphicon-new-window"> </span></a></td><td><a class="wishart-link-out" href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs1142345" target="_blank">rs1142345 <span class="glyphicon glyphicon-new-window"> </span></a></td><td>TMPT*3C</td><td>G Allele</td><td>Hepatotoxicity</td><td><span class="citation"><a class="pubmed-link wishart-link-out" data-toggle="tooltip" href="http://www.ncbi.nlm.nih.gov/pubmed/16509759" target="_blank" title="Bosch TM, Meijerman I, Beijnen JH, Schellens JH: Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet. 2006;45(3):253-85.">16509759 <span class="glyphicon glyphicon-new-window"> </span></a></span></td></tr><tr><td>Thiopurine S-methyltransferase<br>Gene symbol: TPMT<br>UniProt: <a class="wishart-link-out" href="http://www.uniprot.org/uniprot/P51580" target="_blank">P51580 <span class="glyphicon glyphicon-new-window"> </span></a></td><td><a class="wishart-link-out" href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs1142345" target="_blank">rs1142345 <span class="glyphicon glyphicon-new-window"> </span></a></td><td>TPMT*3C</td><td>T &gt; C</td><td>Patients with CC or CT genotype have decreased inactivation of thiopurines and increased risk of toxicity</td><td><span class="citation"><a class="pubmed-link wishart-link-out" data-toggle="tooltip" href="http://www.ncbi.nlm.nih.gov/pubmed/22846425" target="_blank" title='# Stocco G, Yang W, Crews KR, Thierfelder WE, Decorti G, Londero M, Franca R, Rabusin M, Valsecchi MG, Pei D, Cheng C, Paugh SW, Ramsey LB, Diouf B, McCorkle JR, Jones TS, Pui CH, Relling MV, Evans WE: PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Hum Mol Genet. 2012 Nov 1;21(21):4793-804. doi: 10.1093/hmg/dds302. Epub 2012 Jul 30. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/22846425'>22846425 <span class="glyphicon glyphicon-new-window"> </span></a></span></td></tr><tr><td>Thiopurine S-methyltransferase<br>Gene symbol: TPMT<br>UniProt: <a class="wishart-link-out" href="http://www.uniprot.org/uniprot/P51580" target="_blank">P51580 <span class="glyphicon glyphicon-new-window"> </span></a></td><td><a class="wishart-link-out" href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs1142345" target="_blank">rs1142345 <span class="glyphicon glyphicon-new-window"> </span></a></td><td>TPMT*3C</td><td>T &gt; C</td><td>Patients with CC or CT genotype have decreased inactivation of thiopurines and increased risk of toxicity</td><td><span class="citation"><a class="pubmed-link wishart-link-out" data-toggle="tooltip" href="http://www.ncbi.nlm.nih.gov/pubmed/9103127" target="_blank" title='# Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE: Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med. 1997 Apr 15;126(8):608-14. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/9103127'>9103127 <span class="glyphicon glyphicon-new-window"> </span></a></span></td></tr></tbody></table></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9607</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9226</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.5057</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.7766</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8049</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.6683</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8493</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7861</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.8273</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5944</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9046</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.907</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9231</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9025</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9733</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>High CYP Inhibitory Promiscuity</td>
        <td>0.7</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          AMES toxic 
        </td>
        <td>
            0.9152
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9182
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9576
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.7519 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.7434
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.8449
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Aaipharma llc</li>
<li>Mylan pharmaceuticals inc</li>
<li>Roxane laboratories inc</li>
<li>Zydus pharmaceuticals usa inc</li>
<li>Prometheus laboratories inc</li>
<li>Bedford laboratories div ben venue laboratories inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.aaipharma.com">AAIPharma Inc.</a></li>
<li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li><a href="http://www.bedfordlabs.com">Bedford Labs</a></li>
<li><a href="http://www.benvenue.com">Ben Venue Laboratories Inc.</a></li>
<li>Cadila Healthcare Ltd.</li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li><a href="http://www.glenmark-generics.com">Glenmark Generics Ltd.</a></li>
<li>Heartland Repack Services LLC</li>
<li><a href="http://www.mallinckrodt.com">Mallinckrodt Inc.</a></li>
<li><a href="http://www.medisca.com">Medisca Inc.</a></li>
<li><a href="http://www.mylan.com">Mylan</a></li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li>Oso Biopharmaceuticals Manufacturing LLC</li>
<li><a href="http://www.pharmedixrx.com">Pharmedix</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.prometheuslabs.com">Prometheus Laboratories Inc.</a></li>
<li><a href="http://www.rebelrx.com">Rebel Distributors Corp.</a></li>
<li>Resolution Chemicals Ltd.</li>
<li><a href="http://www.roxane.com">Roxane Labs</a></li>
<li><a href="http://www.salix.com">Salix Pharmaceuticals</a></li>
<li><a href="http://www.sandoz.ca">Sandoz</a></li>
<li><a href="http://www.udllabs.com">UDL Laboratories</a></li>
<li>Vangard Labs Inc.</li>
<li><a href="http://www.xanodyne.com">Xanodyne Pharmaceuticals Inc.</a></li>
<li><a href="http://www.zydususa.com">Zydus Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Injection, powder, for solution</td><td>Intravenous</td><td>100 mg</td></tr><tr><td>Tablet</td><td>Oral</td><td>50 mg, 75 mg, 100 mg</td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01418">Acenocoumarol</a></td><td>Azathioprine may decrease the anticoagulant effect of acenocoumarol.</td></tr><tr><td><a href="/drugs/DB00437">Allopurinol</a></td><td>Allopurinol may increase the effect of thiopurine, azathioprine.</td></tr><tr><td><a href="/drugs/DB00233">Aminosalicylic Acid</a></td><td>Aminosalicylic acid may increase the toxicity of thiopurine, azathioprine.</td></tr><tr><td><a href="/drugs/DB01125">Anisindione</a></td><td>Azathioprine may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00732">Atracurium</a></td><td>The agent decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB06168">Canakinumab</a></td><td>results in increased immunosuppressive effects; increases the risk of infection. </td></tr><tr><td><a href="/drugs/DB00266">Dicoumarol</a></td><td>Azathioprine may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01135">Doxacurium chloride</a></td><td>The agent decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB04854">Febuxostat</a></td><td>Coadministration of febuxostat with xanthine oxidase substrate drugs (azathioprine, mercaptopurine or theophylline) could increase plasma concentrations of these drugs, since these drugs are metabolized by xanthine oxidase, resulting in severe toxicity; hence their concomitant use is contraindicated. Since febuxostat does not inhibit or induce cytochrome P450 enzymes it lacks significant drug interactions with other drugs metabolized of these enzymes.</td></tr><tr><td><a href="/drugs/DB00244">Mesalazine</a></td><td>Mesalazine may increase the toxicity of thiopurine, azathioprine.</td></tr><tr><td><a href="/drugs/DB01336">Metocurine</a></td><td>The agent decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01226">Mivacurium</a></td><td>The agent decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01250">Olsalazine</a></td><td>Olsalazine may increase the toxicity of thiopurine, azathioprine.</td></tr><tr><td><a href="/drugs/DB01337">Pancuronium</a></td><td>The agent decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB06372">Rilonacept</a></td><td>results in increased immunosuppressive effects; increases the risk of infection. </td></tr><tr><td><a href="/drugs/DB00795">Sulfasalazine</a></td><td>Sulfasalazine may increase the toxicity of thiopurine, azathioprine.</td></tr><tr><td><a href="/drugs/DB00519">Trandolapril</a></td><td>Trandolapril may increase the risk of neutropenia. Monitor for increased toxic effects of Azathioprine if Trandolapril is initiated or dose increased. </td></tr><tr><td><a href="/drugs/DB00072">Trastuzumab</a></td><td>Trastuzumab may increase the risk of neutropenia and anemia. Monitor closely for signs and symptoms of adverse events. </td></tr><tr><td><a href="/drugs/DB01199">Tubocurarine</a></td><td>The agent decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01339">Vecuronium</a></td><td>The agent decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00682">Warfarin</a></td><td>Azathioprine may decrease the anticoagulant effect of warfarin.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Take with food to reduce irritation.</li></ul></td></tr></tbody></table>